This is the authors' abstract. We don't add key points for this paper.
Several chiral azobenzene compounds having different chiral substituents were synthesized. A cholesteric phase was induced by mixing each chiral azobenzene compound with a host non-chiral nematic liquid crystal (E44). The helical twisting power (HTP) as well as the change in HTP by trans-cis photoisomerization of the chiral azobenzene compound was dependent on the structure of the chiral substituents. A compensated nematic phase was induced by combination of E44, a chiral azobenzene compound and a non-photochromic chiral compound. Reversible switching between the compensated nematic phase and cholesteric phase was brought about by trans-cis photoisomerization of the chiral azobenzene compound in the liquid crystalline systems. An azobenzene compound substituted with a menthyl group showed the highest efficiency as the trigger for the switching; this efficiency was related to the compactness of the chiral group substituted within the azobenzene core moiety.
No takes yet. Share an insight, caveat, or question.
Yoshioka et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: